Prevalence of palmoplantar psoriasis and pustular psoriasis in children

Study identification

• PURI:
  https://redirect.ema.europa.eu/resource/104294
• EU PAS number:
  EUPAS104293
• Study ID:
  104294
• Official title and acronym:
  Prevalence of palmoplantar psoriasis and pustular psoriasis in children
• DARWIN EU® study:
  No
• Study countries:
  France

  Germany

  Romania

  United Kingdom
• Study description:
  A descriptive study of the prevalence of palmoplantar and pustular psoriasis in children 0-11 and 12-17 years during the last 10 years.
• Study status:
  Finalised

Research institutions and networks

Institutions

European Medicines Agency (EMA)

Study timelines

Date when funding contract was signed

Planned: 25/05/2022

Actual: 25/05/2022

Study start date

Planned: 25/05/2022

Actual: 25/05/2022

Date of final study report

Planned: 16/06/2022

Actual: 16/06/2022

Sources of funding

EMA

Study protocol

Initial protocol

Analysis Plan_Palmoplantar Psoriasis_for publication_CLEAN

Regulatory

• Was the study required by a regulatory body?:
  Yes
• Is the study required by a Risk Management Plan (RMP)?:
  Not applicable